Jim Cramer Discussed These 21 Stocks As Bond Yields Soared

Page 12 of 19

8. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holders In Q3 2024: 61

Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical firm that is one of the players in the global weight loss drug industry. Its Wegovy weight loss drug has enabled the firm to grow revenue in the double digits. However, 2025 has gotten off to a slow start for Novo Nordisk A/S (NYSE:NVO). The company was dealt a setback when its recent trial of a weight loss drug missed investor expectations of reducing weight by 25% in December which sent the shares sinking by 17.8%. Cramer’s remarks surrounded the potential for Novo Nordisk A/S (NYSE:NVO) to be caught up in a diplomatic row between the US and Denmark:

“I was going to go to Navarro, because I’m long Eli Lilly with my charitable trust, and say what do got, are you guys going to slam Novo Nordisk? Denmark’s biggest export. You wanna put, you wanna put the jugular? That’s Denmark’s jugular.

“Well no Denmark it could lose Novo Nordisk, it could be great for Eli Lilly.”

Page 12 of 19